Investigative law firm Pomerantz LLP examines potential securities fraud & unlawful practices by Zentalis Pharmaceuticals after an FDA partial clinical hold on drug azenosertib.
Investigative law firm Pomerantz LLP examines potential securities fraud & unlawful practices by Zentalis Pharmaceuticals after an FDA partial clinical hold on drug azenosertib. This led to a stock price drop, prompting the firm to invite investors to join a class action investigation. Pomerantz has a history of fighting securities fraud & corporate misconduct, recovering billions for class members.
July 25, 2024
3 Articles